MedTrace Logo

Retrospective Study on Referral Patterns for High Risk Patients Post Nephrectomy

NCT04309617 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 618

Last updated 2021-05-19

Study results available
· View outcomes & findings →

Summary

This study aims at estimating the proportion of patients diagnosed with locoregional renal cell carcinoma who are at high risk for recurrence following nephrectomy, describe referral patterns, and characterize treatment in this population. Outcomes including estimation of the incidence of recurrence and disease-free interval following nephrectomy will be reported overall and among the subgroup off patients receiving adjuvant systemic therapy with sunitinib following nephrectomy.

Conditions

Interventions

PROCEDURE

nephrectomy

Surgery performed within the study period

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-31
Primary Completion
2020-04-28
Completion
2020-04-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04309617 on ClinicalTrials.gov